Exploitable radiobiological mechanisms in radiochemotherapy;Strahlenbiologische mechanismen fur neue strategien der radiochemotherapie

Strahlentherapie und Onkologie

Volumn 174, Issue 8, 1998, Pages 421-426

  Trott, Klaus Rüdiger ^a,b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Acute normal tissue damage; Additivity; Chronic normal tissue damage; Radiotherapy chemotherapy interactions; Synergism; Tumor cute

Indexed keywords

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DRUG POTENTIATION; HUMAN; SQUAMOUS CELL CARCINOMA; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; RADIOBIOLOGY; RADIOTHERAPY; REVIEW;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASMS; RADIOBIOLOGY; RADIOTHERAPY;

EID: 0031869040     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038564     Document Type: Article

References (26)

1. Bagshaw MA. Possible role of potentiators in radiation therapy. Am J Radiol 1961;85:822-33.
2. Bases RE. Modification of the radiation response determined by single-cell technics: Actinomycin D. Cancer Res 1959;19:1223-9.
3. Belli JA, Piro AJ. The interaction between radiation and adriamycin damage in mammalian cells. Cancer Res 1977;37:1624-30.
4. Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiother Oncol 1994;31:1-11.
5. Berry RJ. Modification of radiation effects. Radiol Clin North Am 1965;3:249-58.
6. Blott P, Trott KR. The effect of actinomycin D on split-dose recovery and repopulation in jejunal crypt cells in vivo. Radiother Oncol 1989;15:73-8.
7. Dewey WC. In vitro systems: standardisation of endpoints. Int J Radiat Oncol Biol Phys 1979;5:1165-74.
8. Dewit L. Combined treatment of radiation and cis-diamminedichloroplatinum: a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987;13:403-26.
9. Dunst J, Sauer R. Simultane Radiochemotherapie. Strahlenther Onkol 1993;169:205-12.
10. Elkind MM, Whitmore GF, Alescio T. Actinomycin D: suppression of recovery in X-irradiated mammalian cells. Science 1964;143:1454-7.
11. Hei TK, Piao CQ, Geard CR, et al. Taxol and ionizing radiation: interaction and mechanisms. Int J Radiat Oncol Biol Phys 1994;29:267-71.
12. Kitahara, T, Liu, K, Solanki, K, et al. Functional and morphological damage after local heart irradiation and/or adriamycin in Wistar rats. Radiat Oncol Invest 1993;1:198-205.
13. Kummermehr, J, Trott, KR. Tumour stem cells. In: Potten C, ed. Stem cells. London: Academic Press, 1997.
14. Milas L, Nakayama T, Hunter N, et al. Dynamics of tumor clonogen repopulation in a murine sarcoma treated with cyclophosphamide. Radiother Oncol 1994;30:247-53.
15. Munro AT. An overview of randomized controlled trials on adjuvant chemotherapy in head and neck cancer. Brit J Cancer 1995;71:83-91.
16. Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer - the time factor. Int J Radiat Oncol Biol Phys 1997;39:831-6.
17. Rubin P. Late effects of chemotherapy and radiation therapy: a new hypothesis. Int J Radiat Oncol Biol Phys 1984;10:5-34.
18. Schultz-Hector S. Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. Int J Radiat Biol 1992;61: 149-60.
19. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979;5:85-91.
20. Stewart LA, Pignon JP, for the Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 1995;311:899-909.
21. Trott KR, Meder G. Die Beeinflussung der Strahlenwirkung auf chinesische Hamsterzellen durch Adriamycin. Strahlentherapie 1981;157:265-71.
22. Trott KR. Chronische Strahlenfolgen nach Radio-Chemotherapie gastrointestinaler Tumoren. GBK Fortbildung aktuell. Krebsdiagn Ther 1994; 64:50-1.
23. Trott KR. Der optimale Zeitpunkt der Bestrahlung bei der Radiochemotherapie mit cis-Platin und Fluoruracil/Folsäure. Strahlenther Onkol 1994;170:117-8.
24. Vokes EE, Weichselbaum RR. Measurable impact: multimodal therapy of head and neck cancer. Int J Radiat Oncol Biol Phys 1993;27:481-2.
25. Ziegler W, Birkenfeld P, Trott KR. The effect of combined treatment of HeLa cells with actinomycin D and radiation upon survival and recovery from radiation damage. Radiother Oncol 1987;10:141-8.
26. Ziegler W, Trott KR. Der Effekt einer kombinierten Behandlung mit cis-Platin und Bestrahlung auf das Überleben von chinesischen Hamsterzellen. Strahlentherapie 1985;161:308-15.